EUVIMEDEUVIMED entdecken
Open Access

Vasoproliferative Tumors of the Retina: Pathophysiology, Clinical Features, and Treatment Approaches

Seung Min Lee, Young Je Choi, Jinsuk Chun, Jee Myung Yang, Min Kim

Ocular Oncology and Pathology · 10.04.2026 · 1-8

DOI: 10.1159/000551914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 10.04.2026. Verfasst von Seung Min Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Institute of Vision Research, Yongin Severance Hospital, Yonsei University College of Medicine, Yonginsi, Republic of Ko…. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Retinal vasoproliferative tumors (RVPTs) are rare, benign lesions appearing as elevated, pink masses in the peripheral retina. Initially considered acquired retinal capillary hemangioblastomas, RVPTs are now recognized as distinct entities, with idiopathic and secondary forms. Though primarily affecting individuals between 30 and 50 years of age, their pathogenesis remains under investigation. Summary: Recent histopathological evidence suggests RVPTs have a predominantly glial rather than vascular origin. Clinically, RVPTs cause visual deterioration, floaters, and photopsia, often with subretinal/intraretinal exudation, epiretinal membranes, vitreous hemorrhage, or retinal detachment. Fluorescein angiography reveals telangiectatic vessels with intense late-phase hyperfluorescence. Secondary RVPTs comprise up to 84% of cases, linked to conditions such as Coats’ disease, uveitis, and toxoplasmosis. Management depends on tumor size, location, and complications. Small, asymptomatic lesions may be observed, while vision-threatening cases require intervention. Treatment options include cryotherapy, laser photocoagulation, photodynamic therapy, intravitreal anti-vascular endothelial growth factor/corticosteroid injections, plaque brachytherapy, and vitreoretinal surgery. While some tumors remain stable without treatment, surgical interventions, particularly pars plana vitrectomy, effectively control complications and tumor activity. Key Messages: The evolving understanding of RVPT pathogenesis necessitates multicenter studies to establish standardized diagnostic and therapeutic guidelines. Integrating histopathological insights with clinical findings will optimize management strategies and improve patient outcomes for these rare retinal tumors.

Schlagwörter

Stichwörter der Autor:innen

Retinal vasoproliferative tumorSurgeryTreatment outcome

Autor:innen und Institutionen

  • Department of Ophthalmology, Institute of Vision Research, Yongin Severance Hospital, Yonsei University College of Medicine, Yonginsi, Republic of Korea.
  • Department of Ophthalmology, Institute of Vision Research, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Ophthalmology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.

Zitieren

APA

Lee, S. M., Choi, Y. J., Chun, J., Yang, J. M., & Kim, M. (2026). Vasoproliferative Tumors of the Retina: Pathophysiology, Clinical Features, and Treatment Approaches. Ocular Oncology and Pathology, 1-8. https://doi.org/10.1159/000551914

Vancouver

Lee SM, Choi YJ, Chun J, Yang JM, Kim M. Vasoproliferative Tumors of the Retina: Pathophysiology, Clinical Features, and Treatment Approaches. Ocular Oncology and Pathology. 2026:1-8. doi:10.1159/000551914

BibTeX
@article{Lee2026,
  author = {Lee, Seung Min and Choi, Young Je and Chun, Jinsuk and Yang, Jee Myung and Kim, Min},
  title = {Vasoproliferative Tumors of the Retina: Pathophysiology, Clinical Features, and Treatment Approaches},
  journal = {Ocular Oncology and Pathology},
  year = {2026},
  pages = {1--8},
  doi = {10.1159/000551914}
}
Kostenlos starten →